Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 21, 2015; 21(27): 8249-8255
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8249
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8249
Figure 2 Tumor-free survival (A) and cumulative survival rates (B) after curative resection of hepatocellular carcinoma.
Figure adapted from Urata et al[44] with permission. Open circles and triangles indicate patients with high serum hepatitis B virus DNA concentrations who were administered and not administered nucleoside analogs, respectively.
- Citation: Kubo S, Takemura S, Tanaka S, Shinkawa H, Nishioka T, Nozawa A, Kinoshita M, Hamano G, Ito T, Urata Y. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2015; 21(27): 8249-8255
- URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8249.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8249